Breast cancer treatment drug Avastin does not appear to extend overall survival of breast-cancer patients and FDA will ask outside medical panel if Genentech’s Avastin should be approved for breast cancer treatment.
Breast cancer treatment drug Avastin does not appear to extend overall survival of breast-cancer patients and FDA will ask outside medical panel if Genentech’s Avastin should be approved for breast cancer treatment.